Lord, Abbett & Co. LLC Amylyx Pharmaceuticals, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Oct 07, 2024
SELL
$20.98 - $31.42 $116,418 - $174,349
-5,549 Reduced 2.22%
244,493 $5.27 Million
Q2 2023

Aug 14, 2023
SELL
$20.98 - $31.42 $116,418 - $174,349
-5,549 Reduced 2.22%
244,493 $5.27 Million
Q1 2023

Oct 07, 2024
BUY
$27.71 - $40.93 $6.93 Million - $10.2 Million
250,042 New
250,042 $7.34 Million
Q1 2023

May 12, 2023
BUY
$27.71 - $40.93 $6.93 Million - $10.2 Million
250,042 New
250,042 $7.34 Million

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email